IN THE NEWS

Below are select recent articles in the press featuring TVAX Biomedical:

Genelux Corporation and TVAX Biomedical, Inc. announce the issuance of a United States patent covering the combination of an adoptive T cell therapy/oncolytic viral cancer treatment that is exclusively licensed to V2ACT Therapeutics™, LLC
BioSpace
June 29, 2023

TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study
Company Press Release
October 18, 2022

TVAX Biomedical Receives Fast Track Designation from the FDA
Company Press Release
April 30, 2020

TVAX Biomedical Names Wayne Carter as President and CEO
Company Press Release
March 11, 2019

ELIAS Animal Health Announces Positive Results in Treatment of Osteosarcoma in Dogs
Company Press Release
October 25, 2018

ELIAS Animal Health Adds Clinical Trial Site for ECI™ for the Treatment of Canine Osteosarcoma
Company Press Release
November 15, 2016

ELIAS Animal Health Announces First Patient Enrolled in Clinical Trial for ECI™ for the Treatment of Canine B-Cell Lymphoma
Company Press Release
August 24, 2016

TVAX secures $2 million financing for animal health subsidiary
Company Press Release
March 2015

Getting Bang for the Buck in a Slow-Growth Economy
KC Business
June 2013

Exploring New Frontiers
Ingram’s Magazine
August 2012